Loading...
Zurn Elkay delivered a solid performance in Q2 2025, driven by 8% core sales growth, improved profitability, and strong free cash flow generation.
Net sales reached $444.5 million, up from $412.0 million in Q2 2024
Adjusted EBITDA margin rose to a record 26.5%
Diluted EPS was $0.29, while adjusted EPS grew to $0.42
Free cash flow exceeded $100 million for the first time
Zurn Elkay raised its full-year 2025 outlook based on Q2 outperformance and continued market stability, with strong expectations for adjusted EBITDA and free cash flow.